JANG; Young Koo

Patent Applications and Registrations

Patent applications and USPTO patent grants for JANG; Young Koo.The latest application filed is for "blend containing carbamate compound for prevention, mitigation, or treatment of schizophrenia".

Company Profile

6.11.16

JANG; Young Koo - Gyeonggi-do KR
JANG; Young Koo - Daejeon KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Blend Containing Carbamate Compound For Prevention, Mitigation, Or Treatment Of Schizophrenia App 20210361622 - JOUNG; Chan Mi ; et al.	2021-11-25
Imidazopyrimidine And Imidazotriazine Derivative, And Pharmaceutical Composition Comprising The Same App 20210300933 - PARK; Chun Eung ; et al.	2021-09-30
Blend containing carbamate compound for prevention, mitigation, or treatment of schizophrenia Grant 11,116,751 - Joung , et al. September 14, 2	2021-09-14
Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same Grant 11,046,702 - Park , et al. June 29, 2	2021-06-29
Pharmaceutical Compositions Comprising Pyridone Derivatives App 20210085658 - MAENG; Cheol Young ; et al.	2021-03-25
Blend Containing Carbamate Compound For Prevention, Mitigation, Or Treatment Of Schizophrenia App 20200281895 - JOUNG; Chan Mi ; et al.	2020-09-10
Imidazopyrimidine And Imidazotriazine Derivative, And Pharmaceutical Composition Comprising The Same App 20200277298 - PARK; Chun Eung ; et al.	2020-09-03
Pharmaceutical Composition Comprising Pyridone Derivatives App 20200000782 - MAENG; Cheol Young ; et al.	2020-01-02
Pharmaceutical composition comprising pyridone derivatives Grant 10,456,385 - Maeng , et al. Oc	2019-10-29
Imidazopyrimidine And Imidazotriazine Derivative, And Pharmaceutical Composition Comprising The Same App 20190031669 - PARK; Chun Eung ; et al.	2019-01-31
Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same Grant 10,100,057 - Park , et al. October 16, 2	2018-10-16
Pharmaceutical Composition Comprising Pyridone Derivatives App 20180263965 - MAENG; Cheol Young ; et al.	2018-09-20
Pharmaceutical composition comprising pyridone derivatives Grant 9,987,259 - Maeng , et al. June 5, 2	2018-06-05
Imidazopyrimidine And Imidazotriazine Derivative, And Pharmaceutical Composition Comprising The Same App 20170349597 - PARK; Chun Eung ; et al.	2017-12-07
Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same Grant 9,745,310 - Park , et al. August 29, 2	2017-08-29
Imidazopyrimidine And Imidazotriazine Derivative, And Pharmaceutical Composition Comprising The Same App 20160251361 - PARK; Chun Eung ; et al.	2016-09-01
Pharmaceutical Composition Comprising Pyridone Derivatives App 20160166552 - Maeng; Cheol Young ; et al.	2016-06-16
Pharmaceutical composition comprising pyridone derivatives Grant 9,271,976 - Maeng , et al. March 1, 2	2016-03-01
Pharmaceutical Composition Comprising Pyridone Derivatives App 20150111901 - MAENG; Cheol Young ; et al.	2015-04-23
Pharmaceutical composition comprising pyridone derivatives Grant 8,952,165 - Maeng , et al. February 10, 2	2015-02-10
Pharmaceutical composition comprising pyridone derivatives Grant 8,716,309 - Maeng , et al. May 6, 2	2014-05-06
Pharmaceutical Composition Comprising Pyridone Derivatives App 20130317059 - Maeng; Cheol Young ; et al.	2013-11-28
Pharmaceutical Composition Comprising Pyridone Derivatives App 20130296340 - Maeng; Cheol Young ; et al.	2013-11-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.